Signal active
Investment Firm
Overview
Lyfebulb is an innovation accelerator that bridges the gap between patient communities and the healthcare industry by working directly with patients and care partners to generate insights, build new solutions, and bring revolutionary products to market. They are a patient empowerment platform that centers around improving the lives of those impacted by chronic disease.
Highlights
2014
Health Care
1-10
1
0
undefined
N/A
N/A
Location
New York, New York, United States, North America
Contact Information
Social
Profile Resume
LyfeBulb, established in 2014 and headquartered in New York, New York, United States, North America., specializes in investments across Women's, Medical Device, Personal Health, Health Diagnostics, Oncology, Primary and Urgent Care. Their recent investments include UE LifeSciences. The highest investment round they participated in was $600.0K. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
1
1
0
undefined
Investments
1
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Mar 20, 2019 | UE LifeSciences | Women's | 25.0K |
Exits
0
Funding Timeline
1
0
1
Funding Rounds
1
LyfeBulb has raised 1 rounds. Their latest funding was raised on Mar 20, 2019 from a Grant - UE LifeSciences round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Mar 20, 2019 | Grant - UE LifeSciences | - | 25.0K | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries